Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2007-04-12 20:35:48 UTC |
---|
Update Date | 2022-03-07 02:49:29 UTC |
---|
HMDB ID | HMDB0006027 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Oxymesterone |
---|
Description | Oxymesterone is an anabolic steroid abused by some athletes and is tested for in regular preventive doping control analysis. Androgenic anabolic steroids (AAS) are defined as natural, synthetic or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic and neuro-endocrine systems, the AAS have been extensively used in sports activities. Oxymesterone and other steroids can be detected in human urine using liquid chromatography/electrospray ionization orthogonal acceleration time-of-flight mass spectrometry (LCoaTOFMS) and gas chromatography/electron ionization orthogonal acceleration time-of-flight mass spectrometry (GCoaTOFMS), using methods that have been developed in order to acquire accurate full scan MS data to be used to detect designer steroids. (PMID: 17610244 , 17667636 , 17723876 , 17723877 , 2079979 , 3308301 , 8456050 , 8674183 , 8725393 , 9216475 ). |
---|
Structure | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(O)C(=O)CC[C@]12C InChI=1S/C20H30O3/c1-18-9-8-16(21)17(22)15(18)5-4-12-13(18)6-10-19(2)14(12)7-11-20(19,3)23/h12-14,22-23H,4-11H2,1-3H3/t12-,13+,14+,18-,19+,20+/m1/s1 |
---|
Synonyms | Value | Source |
---|
4,17beta-Dihydroxy-17alpha-methylandrost-4-en-3-one | Kegg | 4-Hydroxy-17alpha-methyltestosterone | Kegg | 4,17b-Dihydroxy-17a-methylandrost-4-en-3-one | Generator | 4,17Β-dihydroxy-17α-methylandrost-4-en-3-one | Generator | 4-Hydroxy-17a-methyltestosterone | Generator | 4-Hydroxy-17α-methyltestosterone | Generator | 17Alpah-methyl-4, 17beta-dihydroxy-androst-4-ene-3-one | MeSH | (17b)- 4,17b-Dihydroxy-17-methyl-androst-4-en-3-one | HMDB | 4,17b-Dihydroxy-17-methyl-androst-4-en-3-one | HMDB | 4,17b-Dihydroxy-17-methylandrost-4-en-3-one | HMDB | 4-Hydroxy-17-methyltestosterone | HMDB | Anamidol | HMDB | Aranabol | HMDB | Oranabol | HMDB | Oxymestrone | HMDB | Theranabol | HMDB | Oxymesterone | KEGG |
|
---|
Chemical Formula | C20H30O3 |
---|
Average Molecular Weight | 318.4504 |
---|
Monoisotopic Molecular Weight | 318.219494826 |
---|
IUPAC Name | (1S,2R,10R,11S,14S,15S)-6,14-dihydroxy-2,14,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one |
---|
Traditional Name | oxymesterone |
---|
CAS Registry Number | 145-12-0 |
---|
SMILES | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(O)C(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C20H30O3/c1-18-9-8-16(21)17(22)15(18)5-4-12-13(18)6-10-19(2)14(12)7-11-20(19,3)23/h12-14,22-23H,4-11H2,1-3H3/t12-,13+,14+,18-,19+,20+/m1/s1 |
---|
InChI Key | RXXBBHGCAXVBES-XMUHMHRVSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Androstane steroids |
---|
Direct Parent | Androgens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Androgen-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 4-hydroxysteroid
- Hydroxysteroid
- Oxosteroid
- 17-hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Cyclic alcohol
- Tertiary alcohol
- Ketone
- Cyclic ketone
- Enol
- Organic oxygen compound
- Organooxygen compound
- Alcohol
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 170 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Oxymesterone,1TMS,isomer #1 | C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=C(O)C(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 2821.9 | Semi standard non polar | 33892256 | Oxymesterone,1TMS,isomer #2 | C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(O[Si](C)(C)C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 2837.2 | Semi standard non polar | 33892256 | Oxymesterone,1TMS,isomer #3 | C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(O)C(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2773.5 | Semi standard non polar | 33892256 | Oxymesterone,2TMS,isomer #1 | C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=C(O[Si](C)(C)C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 2835.0 | Semi standard non polar | 33892256 | Oxymesterone,2TMS,isomer #2 | C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=C(O)C(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2816.1 | Semi standard non polar | 33892256 | Oxymesterone,2TMS,isomer #3 | C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2779.2 | Semi standard non polar | 33892256 | Oxymesterone,3TMS,isomer #1 | C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2756.9 | Semi standard non polar | 33892256 | Oxymesterone,3TMS,isomer #1 | C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2866.7 | Standard non polar | 33892256 | Oxymesterone,3TMS,isomer #1 | C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3006.7 | Standard polar | 33892256 | Oxymesterone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@@]1(C)CC[C@H]2[C@@H]3CCC4=C(O)C(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 3067.6 | Semi standard non polar | 33892256 | Oxymesterone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=C2CC[C@H]3[C@@H]4CC[C@](C)(O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CCC1=O | 3077.9 | Semi standard non polar | 33892256 | Oxymesterone,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O)CC[C@H]1[C@@H]3CC[C@](C)(O)[C@@]3(C)CC[C@@H]12 | 3041.0 | Semi standard non polar | 33892256 | Oxymesterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C2CC[C@H]3[C@@H]4CC[C@](C)(O[Si](C)(C)C(C)(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CCC1=O | 3305.0 | Semi standard non polar | 33892256 | Oxymesterone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O)CC[C@H]1[C@@H]3CC[C@](C)(O[Si](C)(C)C(C)(C)C)[C@@]3(C)CC[C@@H]12 | 3320.7 | Semi standard non polar | 33892256 | Oxymesterone,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O[Si](C)(C)C(C)(C)C)CC[C@H]1[C@@H]3CC[C@](C)(O)[C@@]3(C)CC[C@@H]12 | 3240.9 | Semi standard non polar | 33892256 | Oxymesterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O[Si](C)(C)C(C)(C)C)CC[C@H]1[C@@H]3CC[C@](C)(O[Si](C)(C)C(C)(C)C)[C@@]3(C)CC[C@@H]12 | 3448.7 | Semi standard non polar | 33892256 | Oxymesterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O[Si](C)(C)C(C)(C)C)CC[C@H]1[C@@H]3CC[C@](C)(O[Si](C)(C)C(C)(C)C)[C@@]3(C)CC[C@@H]12 | 3321.3 | Standard non polar | 33892256 | Oxymesterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O[Si](C)(C)C(C)(C)C)CC[C@H]1[C@@H]3CC[C@](C)(O[Si](C)(C)C(C)(C)C)[C@@]3(C)CC[C@@H]12 | 3305.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Oxymesterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0w2l-0192000000-c77a5a7f23ff006d9beb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Oxymesterone GC-MS (2 TMS) - 70eV, Positive | splash10-0002-1015900000-9a5c2150ebe81a2b37e4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Oxymesterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 10V, Positive-QTOF | splash10-0uxr-0019000000-037f1c6e9e4af67115cc | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 20V, Positive-QTOF | splash10-0uxr-0395000000-ac27272e013004d3c409 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 40V, Positive-QTOF | splash10-0fri-6590000000-3f66aaa1c358f70406b3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 10V, Negative-QTOF | splash10-014i-0029000000-9dfed808b489b6475143 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 20V, Negative-QTOF | splash10-014i-0059000000-87583a19ad53286aa103 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 40V, Negative-QTOF | splash10-0ukd-2092000000-00f7e9d4636c3a765f9f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 10V, Negative-QTOF | splash10-014i-0009000000-062ad2a35e11d303cf23 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 20V, Negative-QTOF | splash10-014i-0019000000-c475af61b990b381eca5 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 40V, Negative-QTOF | splash10-015i-0093000000-05b135598734362e0fa1 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 10V, Positive-QTOF | splash10-0gb9-0019000000-62110441f5c1bc055100 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 20V, Positive-QTOF | splash10-01rl-1971000000-767ae77519d3526768de | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Oxymesterone 40V, Positive-QTOF | splash10-0006-1920000000-e669bfd6083f9462e7a3 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
General References | - Georgakopoulos CG, Vonaparti A, Stamou M, Kiousi P, Lyris E, Angelis YS, Tsoupras G, Wuest B, Nielen MW, Panderi I, Koupparis M: Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun Mass Spectrom. 2007;21(15):2439-46. [PubMed:17610244 ]
- Furlanello F, Serdoz LV, Cappato R, De Ambroggi L: Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil. 2007 Aug;14(4):487-94. [PubMed:17667636 ]
- Kerr JM, Congeni JA: Anabolic-androgenic steroids: use and abuse in pediatric patients. Pediatr Clin North Am. 2007 Aug;54(4):771-85, xii. [PubMed:17723876 ]
- Smurawa TM, Congeni JA: Testosterone precursors: use and abuse in pediatric athletes. Pediatr Clin North Am. 2007 Aug;54(4):787-96, xii. [PubMed:17723877 ]
- Yesalis CE, Anderson WA, Buckley WE, Wright JE: Incidence of the nonmedical use of anabolic-androgenic steroids. NIDA Res Monogr. 1990;102:97-112. [PubMed:2079979 ]
- Hatton CK, Catlin DH: Detection of androgenic anabolic steroids in urine. Clin Lab Med. 1987 Sep;7(3):655-68. [PubMed:3308301 ]
- Brower KJ: Anabolic steroids. Psychiatr Clin North Am. 1993 Mar;16(1):97-103. [PubMed:8456050 ]
- Schanzer W: Metabolism of anabolic androgenic steroids. Clin Chem. 1996 Jul;42(7):1001-20. [PubMed:8674183 ]
- Lukas SE: CNS effects and abuse liability of anabolic-androgenic steroids. Annu Rev Pharmacol Toxicol. 1996;36:333-57. [PubMed:8725393 ]
- Catlin DH, Hatton CK, Starcevic SH: Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes' urine. Clin Chem. 1997 Jul;43(7):1280-8. [PubMed:9216475 ]
|
---|